2024-01-01 2024-12-31 false No description of principal activity Capium Accounts Production 1.1 11205380 2024-01-01 2024-12-31 11205380 bus:AbridgedAccounts 2024-01-01 2024-12-31 11205380 bus:FRS102 2024-01-01 2024-12-31 11205380 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 11205380 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 11205380 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 11205380 2024-01-01 2024-12-31 11205380 2024-12-31 11205380 bus:RegisteredOffice 2024-01-01 2024-12-31 11205380 core:WithinOneYear 2024-12-31 11205380 core:AfterOneYear 2024-12-31 11205380 1 2024-01-01 2024-12-31 11205380 bus:Director1 2024-01-01 2024-12-31 11205380 bus:Director1 2024-12-31 11205380 bus:Director1 2023-01-01 2023-12-31 11205380 2023-01-01 11205380 bus:LeadAgentIfApplicable 2024-01-01 2024-12-31 11205380 2023-01-01 2023-12-31 11205380 2023-12-31 11205380 core:WithinOneYear 2023-12-31 11205380 core:AfterOneYear 2023-12-31 11205380 bus:EntityAccountantsOrAuditors 2023-01-01 2023-12-31 11205380 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 11205380 bus:OrdinaryShareClass1 2024-12-31 11205380 bus:OrdinaryShareClass1 2023-01-01 2023-12-31 11205380 bus:OrdinaryShareClass1 2023-12-31 11205380 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 11205380 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 11205380 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-12-31 11205380 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 11205380 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 11205380 core:Non-currentFinancialInstruments 2024-12-31 11205380 core:Non-currentFinancialInstruments 2023-12-31 11205380 core:ShareCapital 2024-12-31 11205380 core:ShareCapital 2023-12-31 11205380 core:RetainedEarningsAccumulatedLosses 2024-12-31 11205380 core:RetainedEarningsAccumulatedLosses 2023-12-31 11205380 dpl:Item1 2024-01-01 11205380 dpl:Item1 2024-12-31 11205380 dpl:Item1 2023-01-01 11205380 dpl:Item1 2023-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 11205380
England and Wales

 

 

 

SAFEGUARD BIOSYSTEMS ASIA LIMITED



Abridged Accounts
 


Period of accounts

Start date: 01 January 2024

End date: 31 December 2024
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Investments 3   54,727 
  54,727 
Current assets      
Debtors 6,767    2,085,820 
Creditors: amount falling due within one year (5,637)   (26,732)
Net current assets 1,130    2,059,088 
 
Total assets less current liabilities 1,130    2,113,815 
Net assets 1,130    2,113,815 
 

Capital and reserves
     
Called up share capital 4 1    1 
Profit and loss account 1,129    2,113,814 
Shareholders' funds 1,130    2,113,815 
 


For the year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006 the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 29 September 2025 and were signed by:


-------------------------------
Howard Sherman
Director
1
General Information
Safeguard Biosystems Asia Limited is a private company, limited by shares, registered in England and Wales, registration number 11205380, registration address Quadrant House 4Thomas More Square, 6th Floor, London, E1W 1YW.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rate of exchange ruling at the statement of financial position date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All foreign exchange differences are included to the income statement.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.
Fixed asset investments
Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.
A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
2.

Average number of employees

Average number of employees during the year was 0 (2023 : 0).
3.

Investments

Cost Loans to participating interests   Total
  £   £
At 01 January 2024 54,727    54,727 
Additions 5,000    5,000 
Disposals (59,727)   (59,727)
At 31 December 2024  

4.

Share Capital

Allotted, called up and fully paid
2024
£
  2023
£
100 Ordinary shares of £0.01 each  
 

5.

Parent Company

The comapny is a wholly owned subsidiary of Safeguard Biosytems Holdings Limited, a company incorporated and registered in England and Wales.

A loan of £2,056,851 owed by Safeguard Biosystems Holdings Limited was written off during the accounting period.

2